-
A Glimpse of Gilead Sciences's Earnings Potential
29 Oct 2025 14:57 GMT
… 7.00
Stock Performance
Shares of Gilead Sciences were trading at $117 … Gilead Sciences is at the bottom.
Delving into Gilead Sciences's Background
Gilead Sciences … therapy Trodelvy (from Immunomedics).
Gilead Sciences: A Financial Overview
Market …
-
US close: Stocks extend gains ahead of Powell speech, tech earnings
28 Oct 2025 22:23 GMT
At the close, the Dow Jones Industrial Average was up 0.34% at 47,706.37, while the S&P 500 advanced 0.23% to 6,890.89, and the Nasdaq Composite saw out the session 0.80% firmer at 23,872.49.
The Dow closed 161.78 points higher on Tuesday, extending …
-
Retail Investors' Top Stocks With Earnings This Week: SoFi, Apple, Meta And More
27 Oct 2025 15:30 GMT
Individual investors are gearing up for a jam-packed week of earnings featuring several big tech names and retail-trader favorites.
Here's a look at the reports Wall Street and investors will be watching.
Monday, Oct. 27
After Market Close:
Bed Bath …
-
eBay Upgraded, Meta Platforms Downgraded: Updated Rankings on Top Blue-Chip Stocks
27 Oct 2025 14:25 GMT
… my updated ratings for 121 stocks.
Source: iQoncept/Shutterstock.com … at least one of these stocks in your portfolio, so you … Inc.
A
C
B
GILD
Gilead Sciences, Inc.
A
B
B
GMAB …
-
CVS Health Delivers Confident Outlook After Q3 Performance, Stock Hits 52-Week High
29 Oct 2025 14:29 GMT
… said it would not add Gilead Sciences Inc.'s (NASDAQ:GILD … .
CVS Price Action: CVS Health shares were up 2.14% at …
-
Triple Negative Breast Cancer Market Driven by Rising Cases and Immunotherapy Advances | DataM Intelligence
29 Oct 2025 13:12 GMT
… Developments:
1. In September 2025, Gilead Sciences, Inc. announced positive data from … :
• Merck & Co., Inc.
• Gilead Sciences, Inc.
• F. Hoffmann-La Roche … these regions currently represent smaller shares, they offer untapped potential. …
-
As Dow Hits Record, High-Yield Dogs of the Dow Still a Bargain
28 Oct 2025 23:31 GMT
… will receive 1.0250 shares of Chevron for each … Eisai, Ridgeback Biotherapeutics, and Gilead Sciences to jointly develop and commercialize … and medical devices. With shares trading at 14.5 times … High-Yielding Warren Buffett Stocks Are Recession-Resistant
The …
-
Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth
28 Oct 2025 03:42 GMT
… and Chief Commercial Officer at Gilead Sciences, Inc. (NASDAQ: GILD), … quot;), exercisable over ordinary shares of £0.001 each … instrument
Identification code
Ordinary shares of £0.001 each … Solvonis Therapeutics Plc ordinary shares: GB00BMD1Z199
b)
Nature of …
-
Nurix Therapeutics Announces Closing of $250.0 Million Registered Offering of Common Stock
27 Oct 2025 11:00 GMT
… offering of 24,485,799 shares of its common stock at … programs under collaboration agreements with Gilead Sciences, Inc., Sanofi S.A. and …
-
StockWatch: Top 3 Biotech ETFs Finally Bounce Back with the Market
26 Oct 2025 20:17 GMT
… Pharmaceuticals (NASDAQ: VRTX), followed by Gilead Sciences (NASDAQ: GILD) and Amgen (NASDAQ … Small-capitalization (small cap) biopharma stocks with market caps from $250 … .
Minerva Neurosciences (NASDAQ: NERV) shares more than doubled, skyrocketing 140% …
About
© 1995-2025